SBRT vs. surgery for lung cancer with lobe spread
Part of Cancer, Lungs & breathing clinical trials.
This study compares two treatments—stereotactic body radiation (SBRT) and surgery—for people whose non-small cell lung cancer has spread into the tissue between the lobes of the lung. The goal is to see which treatment leads to better long‑term results for this specific type of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have non-small cell lung cancer that has spread into the thin layer between the lobes of your lung but hasn't spread outside the chest
- Your cancer is at a stage that could be treated with either radiation (SBRT) or surgery
- Your overall health is good enough to allow you to be up and about (ECOG score 0–2)
- You haven't had another cancer or serious heart/lung disease in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and effective a type of focused radiation called SBRT is for cancer tumors in certain chest locations. It’s meant for people whose tumor is small (up to 5 cm) and who don’t have widespread, uncontrolled spread.
This trial tests a combination of targeted radiation (SBRT), an immunotherapy drug (tislelizumab), and a targeted therapy (anlotinib) given before surgery for people with a certain type of lung cancer that has not spread too far. It aims to see if this approach can shrink the tumor and improve outcomes.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This trial compares two treatments—radiation (SBRT) and surgery—for people with a small liver tumor (≤5 cm) that hasn't spread. The goal is to see which treatment works better.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.